Schizoaffective Disorders Not Yet Recruiting Phase 2 Trials for Acetylcysteine (DB06151)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03510741Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.Other